Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DeepCell

Financiado

Learning and modeling the molecular response of single cells to drug perturbatio...

Learning and modeling the molecular response of single cells to drug perturbations Advances in single-cell genomics (SCG) allow us to read out a cell’s molecular state with unprecedented detail, increasingly so across perturbations. To fully understand a cellular system, one must be able to predict its internal... ver más

31/12/2027

HMGU

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-11-28

ERC-2021-ADG: ERC ADVANCED GRANTS Scope:Objectives

I+D

Cerrada hace 3 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

HMGU

2.10M€ | Lider

GRL

393.39K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Genome2Cells Decoding animal genomes into cell types 3M€ Cerrado

PTQ2021-011654 DESARROLLO DE MODELOS PREDICTIVOS PARA INTERACCIONES MOLECUL... 99K€ Cerrado

MULTIview-CELL Integration of single-cell multi-omics data across space and... 1M€ Cerrado

BioGeMT Bioinformatics for Genomics in Malta 2M€ Cerrado

PID2020-119535RB-I00 UTILIZACION DE BIG DATA BIOLOGICA PARA AVANZAR HACIA UNA FAR... 303K€ Cerrado

RYC2019-026768-I Advanced molecular simulations for fragment-based lead disco... 309K€ Cerrado

Duración del proyecto: 61 meses Fecha Inicio: 2022-11-28
Fecha Fin: 2027-12-31

Líder del proyecto

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Advances in single-cell genomics (SCG) allow us to read out a cell’s molecular state with unprecedented detail, increasingly so across perturbations. To fully understand a cellular system, one must be able to predict its internal state in response to all perturbations. Yet such modeling in SCG is currently limited to descriptive statistics. Building upon my expertise in machine learning, I propose to systematically model a cell’s behavior under perturbation, focusing on the largely untouched area of drug-induced perturbations with multiomics SCG readouts. A sufficiently generic model will predict perturbed cellular states, enabling the design of optimal treatments in new cell-types. In a pilot study, we predicted gene expression changes of a cell ensemble in response to stimuli. DeepCell builds upon this approach: Based on a multi-condition, multi-modal deep-learning approach for both normal and spatially-resolved genomics, we will set up a constrained, interpretable model for the cellular expression response to diverse perturbations. The added flexibility of the DeepCell model versus classical small-scale systems biology models will allow us to interrogate the effects of combined drug stimuli and characterize the gene regulatory landscape by interpretation of the learned deep network. DeepCell provides unique possibilities to capitalize on cell-based drug screens to address fundamental questions in gene regulation and predicting treatment outcomes. As a proof of concept, I will identify targets that regulate enteroendocrine lineage selection in the intestine. I will set up a 500-compound single-cell organoid RNA-seq screen based on compounds from a spatial imaging screen across 200,000 intestinal organoids, both of which we will model with DeepCell. We will leverage those models to predict optimal treatment for obese mice. DeepCell opens up the possibility of in silico drug screens, with the potential to expedite drug discovery and impact clinical settings.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores